An interventional study of comparing efficacy of TENS and PEMF in knee osteoarthritis in Knee Osteoarthritis, sponsored by University Tunis El Manar. Recruiting at 1 site in Tunisia. Per ClinicalTrials.gov, last updated 2024-05-09.
Sponsored by University Tunis El Manar · Not applicable, Interventional, and Treatment
The effectiveness of PEMF in improving physical function among Osteoarthritic (OA) patients remains a topic of debate, leading to the American College of Rheumatology not yet endorsing its use in OA treatment. Therefore, it's essential to investigate PEMF therapy's efficacy in alleviating joint pain, stiffness, and enhancing physical function in knee OA patients Our study objectives were to evaluate the effectiveness and safety of PEMF therapy and to compare its efficacy with TENS in knee OA management.
4,398 studies on the registry are indexed under Osteoarthritis; 583 are open to participants now.
This study's planned enrollment of 60 is below the median of 70 across 3,440 interventional studies indexed under Osteoarthritis.
Browse Osteoarthritis studies →University Tunis El Manar is the lead sponsor of 73 studies on the registry; 12 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Knee pain AND presence of at least three of the following 6 criteria:
Exclusion Criteria:
For both groups, we did not include:
Device: comparing efficacy of TENS and PEMF in knee osteoarthritis
Device: comparing efficacy of TENS and PEMF in knee osteoarthritis
Sessions will be conducted by a physiotherapist from the center, trained in the technique.Three sessions per week for three weeks. We used an Automatic Program (approximately 20 minutes). For each group, the physical therapy was given as below: G2: Patients treated with magnetotherapy: -Device used: a prototype of a Health magnetic therapy (H.M.T) generator developed by a group of engineering researchers at the University of Tunis El Manar, employing low-frequency electromagnetic waves. The chosen program is "Analgesia". An applicator containing magnets will be placed on the affected knees. The patient will sit on a chair bending knees. G1 : Patients treated with TENS -Device used: TENS from ECO2 from Schwa Medico, 2016, France. We chose the "Gate control" program (high frequency). The patient will sit with bent knees on a chair and adhesive patches will be placed on the affected knee. The intensity will be adapted to the patient's tolerance in both groups.
response to physical therapy
a 20 percent decrease in the total score of WOMAC pain
Time frame: one week before the beginning and 3 weeks after the finishing of the rehabilitation program
reduction of pain
Reduction in visual analog scale (VAS) pain scores at rest and during activity.
Time frame: one week before the beginning and 3 weeks after the finishing of the rehabilitation program
Consumption of paracetamol
Time frame: one week before the beginning and 3 weeks after the finishing of the rehabilitation program
assessing safety
occurrence of adverse effects requiring temporary or permanent discontinuation of the technique.
Time frame: one week before the beginning and 3 weeks after the finishing of the rehabilitation program
assessing patients satisfaction
Satisfaction VAS
Time frame: one week before the beginning and 3 weeks after the finishing of the rehabilitation program
stiffness and function improvement
• Improvement in all three domains of WOMAC and overall WOMAC score: Stiffness (2 questions) and function (17 questions) WOMAC subscales
Time frame: one week before the beginning and 3 weeks after the finishing of the rehabilitation program
Plan to share: Undecided
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Tunis El Manar